$0 is the total value of R. G. NIEDERHOFFER CAPITAL MANAGEMENT INC's 0 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 104.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | 00 | $0 | – | 0 | +100.0% | 0.00% | – | |
VRX | Exit | Valeant Pharmaceuticals International Inc | $0 | – | -1,300 | -100.0% | -1.14% | – |
UNH | Exit | UnitedHealth Group Inc | $0 | – | -2,700 | -100.0% | -1.54% | – |
REGN | Exit | Regeneron Pharmaceuticals Inc | $0 | – | -700 | -100.0% | -1.60% | – |
BIDU | Exit | Baidu Inc | $0 | – | -2,700 | -100.0% | -1.83% | – |
INTC | Exit | Intel Corp | $0 | – | -13,300 | -100.0% | -1.98% | – |
FXI | Exit | iShares China Large-Cap ETFetf | $0 | – | -11,400 | -100.0% | -2.00% | – |
GE | Exit | General Electric Co | $0 | – | -16,500 | -100.0% | -2.05% | – |
DOW | Exit | Dow Chemical Co | $0 | – | -10,600 | -100.0% | -2.22% | – |
NFLX | Exit | Netflix Inc | $0 | – | -4,400 | -100.0% | -2.24% | – |
XLV | Exit | Health Care Select Sector SPDR Fundetf | $0 | – | -7,200 | -100.0% | -2.35% | – |
ABBV | Exit | AbbVie Inc | $0 | – | -9,100 | -100.0% | -2.44% | – |
AAPL | Exit | Apple Inc | $0 | – | -5,300 | -100.0% | -2.89% | – |
AMGN | Exit | Amgen Inc | $0 | – | -5,100 | -100.0% | -3.48% | – |
SLB | Exit | SCHLUMBERGER LTD | $0 | – | -11,400 | -100.0% | -3.88% | – |
BIIB | Exit | Biogen Idec Inc | $0 | – | -2,700 | -100.0% | -3.89% | – |
XLE | Exit | Energy Select Sector SPDR Fundetf | $0 | – | -13,000 | -100.0% | -3.92% | – |
TSLA | Exit | Tesla Motors Inc | $0 | – | -4,000 | -100.0% | -4.90% | – |
FB | Exit | Facebook Inc | $0 | – | -11,400 | -100.0% | -5.06% | – |
YHOO | Exit | Yahoo! Inc | $0 | – | -37,000 | -100.0% | -5.28% | – |
MDT | Exit | Medtronic PLC | $0 | – | -19,600 | -100.0% | -6.48% | – |
IBB | Exit | iShares Nasdaq Biotechnology Etfetf | $0 | – | -5,300 | -100.0% | -7.94% | – |
CVX | Exit | Chevron Corp | $0 | – | -22,700 | -100.0% | -8.84% | – |
CELG | Exit | Celgene Corp | $0 | – | -18,500 | -100.0% | -9.88% | – |
GILD | Exit | Gilead Sciences Inc | $0 | – | -25,100 | -100.0% | -12.17% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-08
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
APPLE INC. | 11 | Q3 2019 | 43.6% |
NETFLIX INC. | 10 | Q2 2018 | 11.4% |
BAIDU INC. - ADS | 10 | Q2 2019 | 7.8% |
BOEING CO/THE | 9 | Q1 2018 | 10.7% |
CELGENE CORPORATION | 8 | Q1 2019 | 12.8% |
VISA INC-CLASS A SHARES | 8 | Q2 2019 | 7.5% |
MICROSOFT CORPORATION | 8 | Q3 2019 | 5.4% |
AMAZON.COM INC. | 7 | Q2 2019 | 13.0% |
WELLS FARGO CO NEW | 7 | Q3 2019 | 7.5% |
QUALCOMM INC | 7 | Q3 2019 | 7.9% |
View R. G. NIEDERHOFFER CAPITAL MANAGEMENT INC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2020-07-31 |
13F-HR | 2020-04-08 |
13F-HR | 2020-02-05 |
13F-HR | 2019-11-06 |
13F-HR | 2019-08-06 |
13F-HR | 2019-05-10 |
13F-HR | 2019-01-24 |
13F-HR | 2018-10-31 |
13F-HR | 2018-08-07 |
13F-HR | 2018-05-14 |
View R. G. NIEDERHOFFER CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.